Morsi Rami Z, Baskaran Archit, Thind Sonam, Carrión-Penagos Julián, Desai Harsh, Kothari Sachin A, Mirza Mahmood, Lazaridis Christos, Goldenberg Fernando, Hurley Michael C, Mendelson Scott J, Prabhakaran Shyam, Zakrison Tanya, Mansour Ali, Kass-Hout Tareq
Department of Neurology, University of Chicago, 5841 S Maryland Ave., MC 2030, Chicago, IL USA.
Cerenovus (Johnson & Johnson), Galway Neuro Technology Center, Galway, Ireland.
Indian J Otolaryngol Head Neck Surg. 2024 Apr;76(2):1554-1562. doi: 10.1007/s12070-023-04357-1. Epub 2023 Dec 8.
There is limited evidence of N-butyl cyanoacrylate (n-BCA) use in endovascular embolization of traumatic face and neck vessel injuries. We investigated the safety and effectiveness of n-BCA for this purpose. We retrospectively analyzed consecutive patients presenting to a Level 1 trauma center between April 2021 and July 2022. We included patients aged ≥ 18 years old with any vessel injury in the face and neck circulation requiring n-BCA embolization. The primary endpoint was n-BCA effectiveness defined as immediate control of active bleeding post-embolization. In total, 13 patients met the inclusion criteria. The median decade of life was 3 (IQR 3 - 5) with a male predominance (n = 11, 84.6%). Median Glasgow Coma Scale score on presentation was 15 (IQR 3-15). Eleven patients suffered gunshot wound injuries; two patients suffered blunt injuries. Injured vessels included facial artery (n = 6, 46.2%), buccal branch artery (n = 3, 23.1%), internal maxillary (n = 5, 38.5%), cervical internal carotid artery (n = 1, 7.7%), and vertebral artery (n = 1, 7.7%). All patients were treated with 1:2 n-BCA to ethiodol mixture with immediate extravasation control. No bleeding recurrence or need for retreatment occurred. One patient died in-hospital (7.7%). Patients were discharged to home (n = 8, 61.5%), day rehabilitation (n = 1, 7.7%), or acute rehabilitation (n = 3, 23.1%). One patient developed a right posterior cerebral artery infarct with hemorrhagic transformation. To our knowledge, this is the first study demonstrating the safety and effectiveness of n-BCA liquid embolism in traumatic vessel injuries, especially penetrating gunshot wounds.
关于使用氰基丙烯酸正丁酯(n-BCA)进行创伤性面颈部血管损伤的血管内栓塞治疗的证据有限。我们为此研究了n-BCA的安全性和有效性。我们回顾性分析了2021年4月至2022年7月期间在一级创伤中心就诊的连续患者。我们纳入了年龄≥18岁、面颈部循环中任何需要n-BCA栓塞治疗的血管损伤患者。主要终点是n-BCA有效性,定义为栓塞后立即控制活动性出血。共有13例患者符合纳入标准。中位年龄为30岁(四分位间距3 - 5),男性占主导(n = 11,84.6%)。就诊时格拉斯哥昏迷量表评分中位数为15(四分位间距3 - 15)。11例患者遭受枪伤;2例患者遭受钝器伤。受伤血管包括面动脉(n = 6,46.2%)、颊支动脉(n = 3,23.1%)、上颌内动脉(n = 5,38.5%)、颈内动脉(n = 1,7.7%)和椎动脉(n = 1,7.7%)。所有患者均接受1:2的n-BCA与碘油混合物治疗,立即控制了外渗。未发生出血复发或再次治疗的需要。1例患者在医院死亡(7.7%)。患者出院回家(n = 8,61.5%)、日间康复(n = 1,7.7%)或急性康复(n = 3,23.1%)。1例患者发生了右侧大脑后动脉梗死并伴有出血性转化。据我们所知,这是第一项证明n-BCA液体栓塞在创伤性血管损伤,尤其是穿透性枪伤中的安全性和有效性的研究。